Research on quaternary ammonium compounds (QACs) and their effectiveness against MRSA highlights their potential as a powerful tool in combating this antibiotic-resistant bacterium. Studies have shown that QACs can effectively kill MRSA by disrupting its cell membrane, leading to cell death. Various methodologies, including in vitro and in vivo experiments, have been used to demonstrate the efficacy of QACs against MRSA. The implications of these findings suggest that QACs could be a valuable alternative for treating MRSA infections, especially in healthcare settings where antibiotic resistance is a growing concern. Further research is needed to explore the full potential of QACs in combating MRSA and other antibiotic-resistant pathogens.